We are glad to inform you that the manuscript by Lydia Scarfò, Silvia Bonfiglio, et al: "BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib" has been accepted for publication on Blood Advances. According to ERIC's policy, the manuscript will be open-access soon.
|